Modular Medical, Inc. (MODD)
3.63
+0.21
(+6.14%)
USD |
NASDAQ |
Sep 04, 13:58
Modular Medical Research and Development Expense (Annual) : 18.30M for March 31, 2026
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 18.30M |
| March 31, 2025 | 14.70M |
| March 31, 2024 | 12.88M |
| March 31, 2023 | 9.062M |
| March 31, 2022 | 7.729M |
| March 31, 2021 | 4.083M |
| March 31, 2020 | 3.034M |
| March 31, 2019 | 1.882M |
| March 31, 2018 | 0.3326M |
| Date | Value |
|---|---|
| June 30, 2016 | |
| June 30, 2015 | |
| June 30, 2014 | |
| June 30, 2013 | 0.00 |
| June 30, 2012 | 0.00 |
| June 30, 2011 | 0.00 |
| June 30, 2010 | 0.00 |
| June 30, 2009 | 0.00 |
| June 30, 2008 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tandem Diabetes Care, Inc. | 174.84M |
| Accuray, Inc. | 37.75M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 65.85M |
| ResMed, Inc. | 378.28M |